Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model

BACKGROUND: Patients with metastatic HER2/neu-positive (HER2/neu +) breast cancer (BC) often experience treatment resistance, disease recurrences and metastases. Thus, new approaches for improving the treatment of HER2/neu + BC to prevent metastatic dissemination are urgently needed. Our previous st...

詳細記述

保存先:
書誌詳細
出版年:Radiat Oncol
主要な著者: Li, Wende, Li, Sen, Chen, Ivy X., Liu, Yujiao, Ramjiawan, Rakesh R., Leung, Chi-Ho, Gerweck, Leo E., Fukumura, Dai, Loeffler, Jay S., Jain, Rakesh K., Duda, Dan G., Huang, Peigen
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7934382/
https://ncbi.nlm.nih.gov/pubmed/33663521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-021-01775-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料